|
SUCLG1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.6242562850266E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
6.249600E-04 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
1.62436730732907E-12 |
| Stage1-vs-Stage2 |
1.940610E-03 |
| Stage1-vs-Stage3 |
5.593700E-02 |
| Stage1-vs-Stage4 |
4.161200E-04 |
| Stage2-vs-Stage3 |
1.202520E-04 |
| Stage2-vs-Stage4 |
1.95439999994829E-06 |
| Stage3-vs-Stage4 |
1.004550E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
1.0910000014519E-08 |
| Normal-vs-Asian |
1.65445435129641E-12 |
| Caucasian-vs-AfricanAmerican |
6.541800E-01 |
| Caucasian-vs-Asian |
9.304200E-01 |
| AfricanAmerican-vs-Asian |
7.525200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.62447832963153E-12 |
| Male-vs-Female |
4.152000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
2.23610019389753E-11 |
| Normal-vs-Age(81-100Yrs) |
6.07070000047116E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.620600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.047810E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.653800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.593600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.225800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.277200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.42799999999876E-05 |
| Classical-VS-Follicular |
9.86988268891764E-14 |
| Classical-VS-Other |
5.353200E-01 |
| Classical-VS-Normal |
1.62447832963153E-12 |
| Tall-VS-Follicular |
1.62436730732907E-12 |
| Tall-VS-Other |
9.242000E-02 |
| Tall-VS-Normal |
1.62436730732907E-12 |
| Follicular-VS-Other |
3.891800E-02 |
| Follicular-VS-Normal |
5.847600E-04 |
| Other-VS-Normal |
6.11389999999323E-05 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.9960036108132E-15 |
| Normal-vs-N1 |
<1E-12 |
| N0-vs-N1 |
7.35249972017016E-10 |
|
|
